News

Relief Therapeutics Reports that Collaboration Partner, NRx Pharmaceuticals, and Quantum Leap Announce Treatment of Severely Ill COVID-19 Patients with Aviptadil in the I-SPY COVID Trial

GENEVA, SWITZERLAND / ACCESSWIRE / July 13, 2021 / RELIEF THERAPEUTICS Holding AG (SIX:RLF, OTCQB:RLFTF) (" Relief "), a biopharmaceutical...

Veracyte Appoints Rebecca Chambers as Executive Vice President and Chief Financial Officer, Further Positioning Company for Global Growth

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--$VCYT--Veracyte, Inc. (Nasdaq: VCYT), a global genomic diagnostics company, today announced the appointment of Rebecca Chambers...

Pharnext Announces First Patient Enrolled in Europe in the PREMIER Trial, its Pivotal Phase III Clinical Study of PXT3003 in Charcot-Marie-Tooth Disease Type 1A (‘CMT1A’)

PARIS, FRANCE / ACCESSWIRE / July 12, 2021 /  Pharnext SA (FR0011191287 - ALPHA) (the 'Company'), an advanced late-stage clinical...

error: Content is protected !!